Ibotta Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
IBTA$59.91+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
| Nine months ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities | ||
| Net (loss) income | $(7,430) | $19,471 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||
| Depreciation and amortization | 6,160 | 5,749 |
| Impairment of capitalized software development costs | 437 | 130 |
| Stock-based compensation expense | 36,253 | 5,307 |
| Common stock warrant expense | 27,084 | 9,052 |
| Credit loss expense | 1,217 | 441 |
| Loss on extinguishment of debt | 9,630 | — |
| Amortization of debt discount and issuance costs | 1,036 | 2,475 |
| Change in fair value of convertible notes derivative liability | 3,085 | 3,200 |
| Other | 36 | 51 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (2,561) | (63,270) |
| Other current and long-term assets | (977) | 472 |
| Accounts payable | 188 | 826 |
| Due to third-party publishers | 23,182 | 26,215 |
| Accrued expenses | (5,926) | (2,773) |
| Deferred revenue | 2,128 | 955 |
| User redemption liability | (4,499) | (7,936) |
| Other current and long-term liabilities | 4,887 | (1,317) |
| Net cash provided by (used in) operating activities | 93,930 | (952) |
| Investing activities | ||
| Additions to property and equipment | (655) | (372) |
| Additions to capitalized software development costs | (7,001) | (5,871) |
| Maturities of short-term investments | — | 27,900 |
| Net cash (used in) provided by investing activities | (7,656) | 21,657 |
| Financing activities | ||
| Proceeds from exercise of stock options | 7,649 | 1,154 |
| Proceeds from initial public offering, net | 206,692 | — |
| Deferred offering costs | (5,972) | (4) |
| Purchase of treasury stock | (15,611) | — |
| Taxes paid related to net share settlement of equity awards | (246) | — |
| Other financing activities | (103) | — |
| Net cash provided by financing activities | 192,409 | 1,150 |
| Net change in cash and cash equivalents | 278,683 | 21,855 |
| Cash and cash equivalents, beginning of period | 62,591 | 17,818 |
| Cash and cash equivalents, end of period | $341,274 | $39,673 |
CONDENSED STATEMENTS OF CASH FLOWS, CONT.
| Nine months ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Supplemental disclosures of cash flow information | ||
| Interest paid | $2,529 | $3,464 |
| Income taxes paid | $8,134 | $1,903 |
| Supplemental disclosures of non-cash investing and financing activities | ||
| Deferred offering costs not yet paid | $65 | $421 |
| Stock-based compensation included in capitalized software development costs | $317 | $320 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.